biote Corp (BTMD) - Total Assets
Based on the latest financial reports, biote Corp (BTMD) holds total assets worth $89.03 Million USD as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check BTMD cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
biote Corp - Total Assets Trend (2019–2025)
This chart illustrates how biote Corp's total assets have evolved over time, based on quarterly financial data. Check BTMD operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
biote Corp - Asset Composition Analysis
Current Asset Composition (December 2025)
biote Corp's total assets of $89.03 Million consist of 50.8% current assets and 49.2% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 22.4% |
| Accounts Receivable | $6.87 Million | 6.4% |
| Inventory | $19.06 Million | 17.7% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $4.27 Million | 4.0% |
| Goodwill | $5.83 Million | 5.4% |
Asset Composition Trend (2019–2025)
This chart illustrates how biote Corp's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market value of biote Corp.
Key Asset Composition Facts
- Current vs. Non-Current Assets: biote Corp's current assets represent 50.8% of total assets in 2025, a decrease from 80.8% in 2019.
- Cash Position: Cash and equivalents constituted 22.4% of total assets in 2025, down from 43.9% in 2019.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 8.0% of total assets, an increase from 7.0% in 2019.
- Asset Diversification: The largest asset category is inventory at 17.7% of total assets.
biote Corp Competitors by Total Assets
Key competitors of biote Corp based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Extendicare Inc
TO:EXE
|
Canada | CA$1.07 Billion |
|
Huaxia Eye Hospital Group Co. Ltd. A
SHE:301267
|
China | CN¥8.17 Billion |
|
Sienna Senior Living Inc
TO:SIA
|
Canada | CA$2.35 Billion |
|
MLP Saglik Hizmetleri AS
IS:MPARK
|
Turkey | TL89.94 Billion |
|
Community Health Systems Inc
NYSE:CYH
|
USA | $13.18 Billion |
|
Hospital Mater Dei S.A
SA:MATD3
|
Brazil | R$4.40 Billion |
|
Lokman Hekim Engurusag Saglik Turizm Egitim Hizmetleri ve Insaat Taahhut AS
IS:LKMNH
|
Turkey | TL5.27 Billion |
|
Ramsay Health Care Ltd
AU:RHC
|
Australia | AU$21.70 Billion |
biote Corp - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.29 | 1.42 | 15.39 |
| Quick Ratio | 0.58 | 1.14 | 15.39 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $8.13 Million | $20.21 Million | $709.77K |
biote Corp - Advanced Valuation Insights
This section examines the relationship between biote Corp's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.96 |
| Latest Market Cap to Assets Ratio | 0.68 |
| Asset Growth Rate (YoY) | -12.1% |
| Total Assets | $107.61 Million |
| Market Capitalization | $72.75 Million USD |
Valuation Analysis
Below Book Valuation: The market values biote Corp's assets below their book value (0.68x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: biote Corp's assets decreased by 12.1% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for biote Corp (2019–2025)
The table below shows the annual total assets of biote Corp from 2019 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $107.61 Million | -12.06% |
| 2024-12-31 | $122.37 Million | -21.20% |
| 2023-12-31 | $155.29 Million | +39.10% |
| 2022-12-31 | $111.64 Million | +105.49% |
| 2021-12-31 | $54.33 Million | +66.72% |
| 2020-12-31 | $32.59 Million | +36.40% |
| 2019-12-31 | $23.89 Million | -- |
About biote Corp
biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with … Read more